Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -804.85%-44.62K | 10.11%-424.19K | -42.00%-307.4K | 332.38%232.38K | -638.39%-344.24K | 95.47%-4.93K | 36.50%-471.88K | -98.69%-216.48K | 65.22%-100K | 82.38%-46.62K |
| Net income from continuing operations | -362.45%-69.3K | 80.51%-1.12M | 85.36%-688.12K | 74.06%-136.34K | 1.11%-280.4K | 93.66%-14.99K | -295.45%-5.75M | -1,023.80%-4.7M | -98.50%-525.6K | 28.73%-283.54K |
| Operating gains losses | 108.63%23.77K | -269.73%-186.25K | -525.54%-255.06K | 2,375.22%256.04K | 156.43%88.17K | -5,534.93%-275.39K | -3.32%109.73K | 236.85%59.94K | 311.40%10.34K | -75.44%34.38K |
| Asset impairment expenditure | --0 | -89.55%422.57K | -91.71%312.07K | -93.41%17.39K | -55.47%7.15K | --85.96K | 1,829.33%4.04M | 3,050.38%3.76M | 216.90%263.94K | 500.07%16.06K |
| Unrealized gains and losses of investment securities | -239.72%-68.24K | 98.49%43.67K | -116.80%-6.22K | 105.62%843 | 100.74%199 | 82.58%48.84K | -51.65%22K | -54.97%37K | 67.86%-15K | 74.43%-26.75K |
| Remuneration paid in stock | ---- | --0 | --0 | --0 | --0 | --0 | -79.16%39.02K | --0 | -69.70%12.86K | -79.71%13.01K |
| Other non cashItems | -53.87%4.15K | -96.30%24.13K | -55.72%282.26K | -2,884.88%-271.61K | 60.05%4.48K | 224.25%9K | 5,901.54%652.79K | 22,329.91%637.46K | 260.02%9.75K | 6.95%2.8K |
| Change In working capital | -54.11%65K | -3.81%391.53K | 1,642.27%323.51K | -40.13%90.22K | -182.99%-163.84K | 77.25%141.64K | 184.28%407.05K | -115.80%-20.98K | 251.22%150.69K | 593.07%197.42K |
| -Change in receivables | -42.89%-6.53K | -112.79%-4.05K | 223.27%3.65K | -102.29%-725 | -68.42%-2.41K | -204.27%-4.57K | 564.93%31.65K | -151.94%-2.96K | 281.33%31.66K | -147.46%-1.43K |
| -Change in prepaid assets | -348.69%-35.72K | 1,386.31%26.38K | 504.67%26.95K | -208.23%-18.3K | 149.79%3.37K | 938.96%14.36K | -96.57%1.78K | -122.68%-6.66K | 151.02%16.91K | -138.25%-6.76K |
| -Change in payables and accrued expense | -18.66%107.24K | -1.18%369.19K | 2,671.37%292.91K | 6.96%109.24K | -180.15%-164.8K | 70.69%131.84K | 280.55%373.59K | -111.66%-11.39K | 308.18%102.13K | 2,533.62%205.61K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | --36 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -804.85%-44.62K | 10.11%-424.19K | 85.88%-31.56K | 53.27%-43.46K | -638.39%-344.24K | 95.47%-4.93K | 36.50%-471.88K | -105.12%-223.48K | 67.66%-93K | 82.38%-46.62K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -79.33%52.09K | 136.22%339.95K | -131.87%-57.3K | 115.81%14.38K | 117.23%130.93K | 194.20%251.95K | -10.02%-938.63K | 330.31%179.78K | 75.20%-90.91K | -71.95%-760.04K |
| Net PPE purchase and sale | ---- | -15.07%-72.41K | ---- | ---- | ---- | --350K | -178.99%-62.93K | -299.63%-62.93K | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | --300K | 494.94%402.87K | --0 | ---- |
| Net investment purchase and sale | --24.02K | 868.14%391.61K | --52.67K | --22.85K | 844.99%316.1K | --0 | -86.85%40.45K | --0 | --0 | --33.45K |
| Net other investing changes | -88.86%28.07K | 102.26%20.75K | -126.86%-37.56K | 90.68%-8.47K | 73.19%-185.17K | 191.80%251.95K | 26.14%-916.15K | 152.06%139.84K | 78.08%-90.91K | -84.51%-690.62K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -79.33%52.09K | 136.22%339.95K | -131.87%-57.3K | 115.81%14.38K | 117.23%130.93K | 194.20%251.95K | -10.02%-938.63K | 330.31%179.78K | 75.20%-90.91K | -71.95%-760.04K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -92.41%105.6K | -1,600,100.00%-16K | 121.6K | 0 | 0 | -9.31%1.39M | 104.17%1 | 0 | -37.90%952.43K | |
| Net issuance payments of debt | ---- | --0 | --0 | --0 | --0 | --0 | --205.08K | --0 | --0 | --187.79K |
| Net common stock issuance | ---- | --0 | ---121.6K | --121.6K | --0 | --0 | -22.33%1.25M | --0 | --0 | -48.44%832.05K |
| Net other financing activities | ---- | 256.66%105.6K | ---- | ---- | ---- | ---- | 15.54%-67.41K | 104.17%1 | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | -92.41%105.6K | -1,600,100.00%-16K | --121.6K | --0 | --0 | -9.31%1.39M | 104.17%1 | --0 | -37.90%952.43K |
| Net cash flow | ||||||||||
| Beginning cash position | -45.24%33.63K | 5.93%61.41K | 255.98%184.56K | -69.24%63.1K | 293.93%296.89K | 5.93%61.41K | -39.93%57.97K | -72.28%51.85K | -75.53%205.09K | 67.07%75.37K |
| Current changes in cash | -96.98%7.47K | 209.06%21.36K | -140.01%-104.86K | 150.30%92.5K | -246.32%-213.3K | 296.91%247.02K | 68.65%-19.59K | 76.64%-43.69K | 71.89%-183.91K | -82.38%145.78K |
| Effect of exchange rate changes | 91.08%-1.03K | -313.44%-49.14K | -186.50%-46.07K | -5.56%28.96K | -27.65%-20.49K | 74.26%-11.54K | -3.86%23.02K | -8.19%53.25K | 957.71%30.66K | 52.90%-16.05K |
| End cash Position | -86.50%40.07K | -45.24%33.63K | -45.24%33.63K | 255.98%184.56K | -69.24%63.1K | 293.93%296.89K | 5.93%61.41K | 5.93%61.41K | -72.28%51.85K | -75.53%205.09K |
| Free cash from | -804.85%-44.62K | 13.60%-496.6K | 68.14%-103.97K | 53.27%-43.46K | -638.39%-344.24K | 95.47%-4.93K | 29.35%-574.74K | -83.93%-326.34K | 67.86%-93K | 82.38%-46.62K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.